ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis

M. Mitrovic1,2, D. Antic1,2, N. Milic3, M. Virijevic1,2, Z. Pravdic1, N. Sabljic1, N. Pantic1, N. Suvajdzic Vukovic1,2

1Clinic for Hematology CCS, Belgrade, Serbia, 2Faculty of Medicine, University of Belgrade, Belgrade, Serbia, 3Faculty of Medicine, University of Belgrade, Institute for Medical Statistics and Informatics, Belgrade, Serbia

Abstract Number: PB1334

Meeting: ISTH 2020 Congress

Theme: Platelet Disorders and von Willebrand Disease » Acquired Thrombocytopenias

Background: Splenectomy may lead to a good response in 60-80% of adults with immune thrombocytopenia (ITP). However, available literature does not seem to contain any precise indications concerning possible factors predicting the response to splenectomy.

Aims: To perform systematic review and meta-analysis in an attempt to identify predictive parameters for good therapy response (GTR) on splenectomy in adult ITP patients.

Methods: MEDLINE, Web of Science, EMBASE, Cochrane trials and reviews were searched from 1966 to 2018 for studies where splenectomised ITP patients were followed to determine predictive parameters for GTR. The primary analysis included all papers. During secondary analyses papers were divided in groups according to used response criteria (first used International Working Group (IWG) criteria; second defined GTR as platelet count (PC)>50×109/L). Both groups were subdivided according to the tested type of response: initial, sustained remission and relapse. Random effects method was used to summarise outcomes. The effect estimates were expressed as odds ratio (OR) or standardised mean difference (SMD) with 95% confidence interval. Strength of evidence was assessed by New-Castle Otawa protocol.

Results: The literature search identified 8451 articles; 35 of them were included in meta-analysis (IWG group included 16 articles and second group 19 articles). Meta-analysis did not reveal any significant predictor for successful splenectomy, in both primary and secondary analysis (p>0.05). Age, sex, the time between diagnosis and surgery, response to steroids, response to IVGs, preoperative PC, antiplatelet antibody, spleen weight, accessory spleen, number of therapy lines, and platelet kinetic were not significantly correlated with response to splenectomy. Low quality of evidence was found for all outcomes.

Conclusions: Our study did not identify any parameter clearly predictive of GTR after splenectomy. Further studies based on appropriate use of standardised criteria for patient recruitment and outcomes are needed to better define splenectomy effect persistence in long term.

To cite this abstract in AMA style:

Mitrovic M, Antic D, Milic N, Virijevic M, Pravdic Z, Sabljic N, Pantic N, Suvajdzic Vukovic N. Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/can-we-predict-the-outcome-of-splenectomy-for-primary-immune-thrombocytopenia-conclusion-based-on-systematic-review-and-meta-analysis/. Accessed August 15, 2022.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/can-we-predict-the-outcome-of-splenectomy-for-primary-immune-thrombocytopenia-conclusion-based-on-systematic-review-and-meta-analysis/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress ยป

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley